Combined Fractional CO₂ Laser and Topical Corticosteroid Versus Topical Corticosteroid Only in the Treatment of Palmoplantar Psoriasis

ConditionPsoriasis
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-60
SponsorCairo University

About this trial

To assess whether adding fractional laser to topical corticosteroid improves treatment outcomes in palmoplanter psoriasis compared to topical corticosteroid alone.

Eligibility criteria

Qualifiers

Adults aged ≥18 years

Stable psoriasis

Confirmed cases of palmoplantar psoriasis (with or without psoriasis elsewhere) dermoscopically(Hand _held dermoscopy) and histopathologically if required.

Willingness to comply with treatment and follow-up

Disqualifiers

Other palmoplantar dermatoses (eczema, tinea, keratoderma)

Generlized Pustular psoriasis

Erythrodermic psoriasis

Systemic antipsoriatic therapy within 3 months

Trial design

Treatments tested in this trial

  • Fractional CO2 laser assisted drug delivery
  • Topical Corticosteroid (TCS)

Treatment groups

32 Participants
are divided into 2 treatment groups

Sponsors and collaborators